Interruption of natalizumab therapy for multiple sclerosis: What are the risks?

Published 2011 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Interruption of natalizumab therapy for multiple sclerosis: What are the risks?
Authors
Keywords
-
Journal
NEUROLOGY
Volume 76, Issue 22, Pages 1854-1855
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-05-05
DOI
10.1212/wnl.0b013e31821d7553

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.